ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 411 filers reported holding ENCOMPASS HEALTH CORP in Q4 2021. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $247,991 | -44.7% | 4,040 | -44.7% | 0.01% | -44.4% |
Q4 2022 | $448,512 | -19.0% | 7,300 | -38.4% | 0.01% | -30.8% |
Q3 2022 | $554,000 | +1.8% | 11,850 | +5.4% | 0.01% | +8.3% |
Q2 2022 | $544,000 | -19.9% | 11,245 | +19.3% | 0.01% | -7.7% |
Q1 2022 | $679,000 | +35.8% | 9,424 | +21.4% | 0.01% | +44.4% |
Q4 2021 | $500,000 | +29.2% | 7,765 | +34.4% | 0.01% | +28.6% |
Q3 2021 | $387,000 | +2.7% | 5,779 | +23.1% | 0.01% | 0.0% |
Q2 2021 | $377,000 | +60.4% | 4,696 | +63.9% | 0.01% | -22.2% |
Q1 2021 | $235,000 | +5.9% | 2,865 | -18.4% | 0.01% | -25.0% |
Q3 2019 | $222,000 | -48.8% | 3,510 | -48.7% | 0.01% | -52.0% |
Q2 2019 | $434,000 | -6.7% | 6,847 | -14.0% | 0.02% | -16.7% |
Q1 2019 | $465,000 | -16.8% | 7,959 | +11.0% | 0.03% | -30.2% |
Q3 2018 | $559,000 | +4.1% | 7,172 | -9.6% | 0.04% | -8.5% |
Q2 2018 | $537,000 | +26.1% | 7,933 | +6.6% | 0.05% | +20.5% |
Q1 2018 | $426,000 | – | 7,443 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Copeland Capital Management, LLC | 569,048 | $28,117,000 | 1.78% |
Kalos Management, Inc. | 76,118 | $3,761,000 | 1.77% |
Bridge City Capital, LLC | 30,231 | $1,494,000 | 1.08% |
DALTON GREINER HARTMAN MAHER & CO | 331,823 | $16,395,000 | 0.86% |
Horrell Capital Management, Inc. | 28,641 | $1,415,000 | 0.74% |
Polianta Ltd | 26,600 | $1,314,000 | 0.43% |
GLOBEFLEX CAPITAL L P | 30,177 | $1,491,000 | 0.42% |
CARILLON TOWER ADVISERS, INC. | 768,748 | $37,984,000 | 0.40% |
EAGLE ASSET MANAGEMENT INC | 1,070,271 | $53,001,000 | 0.29% |
S. R. Schill & Associates | 8,108 | $401,000 | 0.25% |